Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. A.I.G Technologies, Inc.
WARNING LETTER
•A.I.G Technologies, Inc.•November 17, 2015

A.I.G Technologies, Inc. – FDA Warning Letter, Nov 17, 2015

Record Details

On September 29, 2015, through November 17, 2015, the FDA inspected AIG Technologies, Inc. in Deerfield Beach, Florida, a contract manufacturer of OTC and prescription drug products. The inspection revealed the manufacture of unapproved and misbranded new drugs, violating sections 301(a), (d), and 505(a) of the FD&C Act.

The unapproved new drug violations include several prescription products like Sodium Sulfacetamide 10% and Sulfur 5% Lotion (NDC 44523-607), 45% Urea Nail Gel (NDC 51862-181), and Formaldehyde 10% (NDC 49908-167), which lack FDA-approved applications. Additionally, the OTC product Derma Numb Tattoo Anesthetic Spray is considered an unapproved new drug because its labeled indications for tattooing are not generally recognized as safe and effective under the TFM for OTC External Analgesics, raising safety concerns due to potential systemic absorption of lidocaine.

The prescription products are also misbranded under section 502(f)(l) of the FD&C Act because they are not safe for use without professional supervision, and adequate directions for lay use cannot be provided.

AIG Technologies, Inc. must immediately discontinue manufacturing and distributing all unapproved new drugs. Within

Company
A.I.G Technologies, Inc.
Inspection date
November 17, 2015
Product type
Drugs
Office
Dallas District Office
People
  • Monica R. Maxwell (Program Division Director)
  • Mary L. Mayleben (Pharmaceutical Program Manager)
  • Christopher Ferguson
View Company Profile

ID · 5f747b6a-f6c9-44ee-9f98-269131c7195c

Violation Codes10
21.U.S.C. 355(a)21 CFR 21121 U.S.C. 331(d)21 U.S.C. 355(b)21 U.S.C. 355(j)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)FD&C Act 505FD&C Act 301FD&C Act 502(f)(1)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore A.I.G Technologies, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.